Cost‐Effectiveness Analysis of Treatments for Children With Uncontrolled Asthma Symptoms Despite Inhaled Corticosteroids
Treatment escalation beyond low-dose ICS in children and adolescents with uncontrolled asthma may only be cost-effective in the UK if the prices of alternatives reduce or treatment is targeted to those at higher risk of asthma exacerbations.
Authors
- Sarah Donegan (ORCID: https://orcid.org/0000-0003-1709-2290)
- Olivia Fulton (ORCID: https://orcid.org/0000-0001-7358-0219)
- Steve Turner (ORCID: https://orcid.org/0000-0001-8393-5060)
- Sofia Cividini (ORCID: https://orcid.org/0000-0003-2705-9224)
- Catrin Tudur Smith (ORCID: https://orcid.org/0000-0003-3051-1445)
- Katie Rose (ORCID: https://orcid.org/0000-0002-2348-2036)
- Dyfrig Hughes (ORCID: https://orcid.org/0000-0001-8247-7459)
- Ian Sinha (ORCID: https://orcid.org/0000-0002-7342-5523)
- Giovanna Culeddu (ORCID: https://orcid.org/0000-0001-5032-4255)
Institutions
- University of Liverpool (GB)
- Bangor University (GB)
- University of Aberdeen (GB)
- House of Representatives (NL)
- NHS Grampian (GB)
- Alder Hey Children's NHS Foundation Trust (GB)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/ppul.71414
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research